Background and objectivesSome patients have insufficient treatment response to conventional disease-modifying antirheumatic drugs (cDMARD); although biologics have proven to be an effective treatment

Figshare2023-07-27 更新20

Outcome data for the BEPKO-2 feasibility study

关节炎治疗评估

临床试验可行性研究

These xls files contains the out data collected from the 82 participants who were recruited into the BEPKO-2 feasibility study. Note that there was missing data from one participant in the CMT group a

Figshare2025-01-09 更新30

Clinical features and treatment of RA, OA, PsA, and SpA patients included in the study.

风湿病研究

关节炎治疗评估

No = number of patients; DoD = duration of disease; IgM-RF = immunoglobulin M-rheumatoid factor; ACPA = anti-citrullinated peptide antibodies; MTX = Methotrexate; NSAIDs = non-steroidal anti-inflammat

Figshare2015-12-02 更新20